Literature DB >> 11687854

The use of interferon for emergency prophylaxis of marburg hemorrhagic fever in monkeys.

A A Kolokol'tsov1, I A Davidovich, M A Strel'tsova, A E Nesterov, O A Agafonova, A P Agafonov.   

Abstract

The possibility of emergency prophylaxis of Marburg hemorrhagic fever with leukocytic and recombinant interferons was studied in experiments on Cercopithecus aethiops. None of the agents protected monkeys from the action of lethal doses of Marburg virus. Recombinant interferon-alpha(2)administered according to the emergency prophylaxis schedule prolonged the mean life-span of monkeys injected with Marburg virus in doses of 100 and 1000 LD50 by 1.9 and 6.1 days, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687854     DOI: 10.1023/a:1012540614713

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  6 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

Review 2.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

Review 3.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Authors:  Elizabeth R Glaze; Michael J Roy; Lonnie W Dalrymple; Lynda L Lanning
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

4.  Early blood profiles of virus infection in a monkey model for Lassa fever.

Authors:  Mahmoud M Djavani; Oswald R Crasta; Juan Carlos Zapata; Zhangjun Fei; Otto Folkerts; Bruno Sobral; Mark Swindells; Joseph Bryant; Harry Davis; C David Pauza; Igor S Lukashevich; Rasha Hammamieh; Marti Jett; Maria S Salvato
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 5.  Correlates of immunity to filovirus infection.

Authors:  Steven B Bradfute; Sina Bavari
Journal:  Viruses       Date:  2011-06-27       Impact factor: 5.048

6.  Transmission potential and design of adequate control measures for Marburg hemorrhagic fever.

Authors:  Marco Ajelli; Stefano Merler
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.